Dosage and administration
chew 2-4 tablets as symptoms occur, or as directed by a doctor
Rolaids Regular Strength Tablets Mint
- Manufacturer
- Chattem, Inc.
- Effective date
- 2022-12-29
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 7
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:42:33
Label at a glance#
ProductRolaids Regular Strength Mint
Active ingredientCALCIUM CARBONATE, MAGNESIUM HYDROXIDE
Label structure26 sections
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Regular Strength Antacid Rolaids Mint 12 Chewable Tablets
Drug Facts
Active ingredient
(in each tablet)
Calcium carbonate USP 550 mg
Magnesium hydroxide USP 110 mg
Purpose
Antacid
Use
relieves:
- heartburn
- sour stomach
- acid indigestion
Warnings
Ask a doctor or pharmacist before use if you are
now taking a prescription drug. Antacids may interact with certain prescription drugs.
When using this product
- do not take more than 12 tablets in a 24-hour period
- do not use the maximum dosage for more than 2 weeks
Keep out of reach of children.
Directions
- chew 2-4 tablets as symptoms occur, or as directed by a doctor
Other information
each tablet contains: calcium 220 mg, magnesium 45 mg
Inactive ingredients
dextrose, flavor, magnesium stearate, silicon dioxide, stearic acid, sucralose, sucrose (309-058)
Dist. by CHATTEM, INC.
P.O. Box 2219
Chattanooga, TN 37409
Regular Strength Antacid Rolaids Mint 150 Chewable Tablets
Drug Facts
Active ingredient
(in each tablet)
Calcium carbonate USP 550 mg
Magnesium hydroxide USP 110 mg
Purpose
Antacid
Use
relieves:
- heartburn
- sour stomach
- acid indigestion
Warnings
Ask a doctor or pharmacist before use if you are
now taking a prescription drug. Antacids may interact with certain prescription drugs.
When using this product
- do not take more than 12 tablets in a 24-hour period
- do not use the maximum dosage for more than 2 weeks
Keep out of reach of children.
Directions
- chew 2-4 tablets as symptoms occur, or as directed by a doctor
Other information
each tablet contains: calcium 220 mg, magnesium 45 mg
Inactive ingredients
dextrose, flavor, magnesium stearate, silicon dioxide, stearic acid, sucralose, sucrose (309-053)
As a daily source of calcium and magnesium, chew 2 tablets twice daily.
| Supplement Facts Serving Size: 2 Tablets, Servings Per Container: 75, Amount Per Serving: Calories 7, Total Carb 1 g (<1% DV*), Sugars 1 g (†DV), Calcium 440 mg (44% DV), Magnesium 90 mg (23% DV). *Percent Daily Values (DV) are based on a 2,000 calories diet. †Daily Value not established. |
Other ingredients
sucrose, dextrose, stearic acid, magnesium stearate, silicon dioxide, flavor, sucralose
Regular Strength Antacid Rolaids Mint 36 Chewable Tablets
Drug Facts
Active ingredient
(in each tablet)
Calcium carbonate USP 550 mg
Magnesium hydroxide USP 110 mg
Purpose
Antacid
Use
relieves:
- heartburn
- sour stomach
- acid indigestion
Warnings
Ask a doctor or pharmacist before use if you are
now taking a prescription drug. Antacids may interact with certain prescription drugs.
When using this product
- do not take more than 12 tablets in a 24-hour period
- do not use the maximum dosage for more than 2 weeks
Keep out of reach of children.
Directions
- chew 2-4 tablets as symptoms occur, or as directed by a doctor
Other information
each tablet contains: calcium 220 mg, magnesium 45 mg
Inactive ingredients
dextrose, flavor, magnesium stearate, silicon dioxide, stearic acid, sucralose, sucrose (309-058)
Dist. by CHATTEM, INC.
P.O. Box 2219
Chattanooga, TN 37409
PRINCIPAL DISPLAY PANEL
REGULAR STRENGTH ANTACID
Rolaids®
12 Mint Chewable Tablets
PRINCIPAL DISPLAY PANEL
REGULAR STRENGTH ANTACID
Rolaids®
Rapid Relief of:
Heartburn
Acid Indigestion
150 Chewable Tablets
Mint
PRINCIPAL DISPLAY PANEL
REGULAR STRENGTH
Rolaids®
ANTACID
Rapid Relief of:
Heartburn
Acid Indigestion
3 Rolls
36 Chewable Tablets
Mint
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 41167-1000-2 | EA - Each | 41167-1000 | 0ceed59e-7e41-455d-9a12-f002d2193e56 | 1 | 2018-03-08 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM CARBONATE | ACTIVE INGREDIENT | H0G9379FGK | 1 | |
| MAGNESIUM HYDROXIDE | ACTIVE INGREDIENT | NBZ3QY004S | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 1 | |
| DEXTROSE | INACTIVE INGREDIENT | IY9XDZ35W2 | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| SUCRALOSE | INACTIVE INGREDIENT | 96K6UQ3ZD4 | 1 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 1 |
Products#
Every source-derived product name is available through these pages.
- Rolaids Regular Strength Mint
- Calcium carbonate and Magnesium hydroxide
- CALCIUM CARBONATE
- CALCIUM CATION
- MAGNESIUM HYDROXIDE
- MAGNESIUM CATION
- DEXTROSE
- MAGNESIUM STEARATE
- SILICON DIOXIDE
- STEARIC ACID
- SUCRALOSE
- SUCROSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 41167-1000 | 41167-1000-5, 41167-1000-1, 41167-1000-2, 41167-1000-3 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CALCIUM CARBONATE | H0G9379FGK | ACTIB |
| MAGNESIUM HYDROXIDE | NBZ3QY004S | ACTIB |
| DEXTROSE | IY9XDZ35W2 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| SUCROSE | C151H8M554 | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 69 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | GRANULE, FOR SUSPENSION / ORAL | 14 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED / ORAL | 3 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | WAFER / ORAL | 66 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION / ORAL | 200 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | LOZENGE / TRANSMUCOSAL | 1255 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, ORALLY DISINTEGRATING / ORAL | 60 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED PELLETS / ORAL | 69 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / BUCCAL | 6 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | SYRUP / ORAL | 620 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 9 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / TOPICAL | 8 %w/w | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, EXTENDED RELEASE / ORAL | 117 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | SUSPENSION, EXTENDED RELEASE / ORAL | 16 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOAP / TOPICAL | 6 %w/w | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / SUBLINGUAL | 9 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION / ORAL | 64 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | INJECTION, SOLUTION / INTRATHECAL | 1925 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRASPINAL | 75 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | LOZENGE / BUCCAL | NA | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | GRANULE / ORAL | 5.4 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / DENTAL | 19 %w/w | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / RESPIRATORY (INHALATION) | 0.13 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / INTRAVITREAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | 336 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET / ORAL | 45 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION, EXTENDED RELEASE / ORAL | 70 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TROCHE / ORAL | 903.5 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | INSERT / VAGINAL | 8 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TROCHE / ORAL | 60 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, DELAYED RELEASE / ORAL | 1060 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | GRANULE, FOR SUSPENSION / ORAL | 23 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | DROPS / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | INHALANT / ORAL | 0.08 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRAMUSCULAR | 5 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0d9b3cbc-7d85-4139-b1c6-c1efbd9244e6 | 2ab0f903-e235-4b35-99f9-131d75400e82 | 2023-04-27 | Warnings | 2ab0f903-e235-4b35-99f9-131d75400e82 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.